Pfizer Archives

Tag: Pfizer

Update from the LRA About CDC Recommendations on Third COVID-19 Vaccine for Immunocompromised Patients

August 13, 2021 – 4:45 PM The Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices voted unanimously to recommend, and CDC Director Rochelle Walensky, MD subsequently approved, that people with moderately to severely weakened immune systems receive a third dose of the COVID-19 Pfizer or Moderna vaccines. The CDC defined the […] Read More

Two Studies Show COVID-19 Vaccines are Well-Tolerated Among Lupus Patients

August 12, 2021 In two recent studies, researchers found that the four COVID-19 vaccines are well-tolerated in lupus patients. Given that the Moderna and Pfizer vaccines are the first mRNA vaccines currently authorized for the emergency use in people, lupus researchers have since worked to answer questions specifically about potential side effects and whether these […] Read More

Update from LRA’s President on COVID-19 Vaccines in Lupus

January 14, 2020 Dear Friends, Happy New Year! On behalf of all of us at the Lupus Research Alliance (LRA), thank you so much for your kindness and generosity in 2020 and prior years. 2021 starts off with some exciting milestones for the lupus community including a new treatment for lupus nephritis. But Recently, our […] Read More

23andMe Study Confirms Lupus Can Run in Families and Other New Insights

August 25, 2020 A study started four years ago and conducted by 23andMe provided many insights about lupus as a complex disease that is extremely difficult to diagnose and treat. While the survey of nearly 6,000 participants did not find new genetic factors causing lupus as hoped, the study confirmed that lupus can run in […] Read More

VALUE Study Results Reported at EULAR

MADRID, Spain. June 13, 2019 – Results of the first clinical trial conducted through the Lupus Research Alliance Lupus Clinical Investigators Network (LuCIN) were presented today at the European Congress of Rheumatology (EULAR) 2019. The study, called VAlidation in LUpus of an Electronic Patient Reported Outcomes Tool (VALUE), showed that a custom smartphone app allowed people with lupus […] Read More

Lupus Research Alliance LuCIN Clinical Trials Network Launches Inaugural Studies

NEW YORK, NY. October 31, 2017 — The Lupus Research Alliance (LRA) announced the first clinical trials to be conducted through the new Lupus Clinical Investigators Network (LuCIN). The LRA organized, manages and funds LuCIN to accelerate thef development of new lupus therapies. Comprising50+ top academic research centers throughout North America, LuCIN provides a framework to quickly […] Read More

App developed by Lupus Research Alliance, Pfizer Inc. and Tata to be tested through non-interventional clinical trial called VALUE

NEW YORK, NY. May 9, 2017— The Lupus Research Alliance and global biopharmaceutical company Pfizer Inc.announced a non-interventional clinical study called VALUE (VAlidation in LUpus of an Electronic Patient Reported Outcomes Tool), to test a custom smartphone app that allows lupus patients to report on their symptoms in real time. Incorporating feedback from people with lupus, the […] Read More